True Private Wealth Advisors Edwards Lifesciences Corp Transaction History

True Private Wealth Advisors

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 16, 2024	BUY	$84.3 - $94.31 $1,854 - $2,074	22 Added 0.98%	2,277 $210,000
Q1 2024 Apr 25, 2024	BUY	$72.54 - $95.56 $163,577 - $215,487	2,255 New	2,255 $215,000
Q1 2021 May 12, 2021	SELL	$78.68 - $90.67 $66,799 - $76,978	-849 Closed	0 $0
Q4 2020 Jan 11, 2021	BUY	$71.69 - $91.23 $6,667 - $8,484	93 Added 12.3%	849 $77,000
Q2 2020 Jul 07, 2020	BUY	$57.54 - $76.95 $32,567 - $43,553	566 Added 297.89%	756 $52,000
Q1 2020 Apr 20, 2020	SELL	$52.41 - $81.0 $2,987 - $4,617	-57 Reduced 23.08%	190 $35,000
Q4 2019 Jan 27, 2020	BUY	$71.7 - $82.09 $17,709 - $20,276	247 New	247 $57,000
Q3 2019 Oct 09, 2019	SELL	$61.55 - $75.43 $8,924 - $10,937	-145 Closed	0 $0
Q2 2019 Aug 01, 2019	BUY	$55.74 - $64.41 $8,082 - $9,339	145 New	145 $26,000
Q4 2018 Jan 14, 2019	SELL	$46.41 - $56.94 $13,273 - $16,284	-286 Closed	0 $0
Q3 2018 Oct 18, 2018	BUY	$45.7 - $58.03 $13,070 - $16,596	286 New	286 $0

1,354

469M

9.76M

3.92M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $44.9B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of True Private Wealth Advisors, based on Form 13F filings with the SEC.

Stay updated on True Private Wealth Advisors with notifications on news.